What should we focus on before preimplantation genetic diagnosis/screening?

Introduction : Preimplantation genetic diagnosis/screening (PGD/PGS) can effectively detect chromosomal abnormalities in an embryo but only if an embryo is available. However, not all couples can obtain an embryo that is available for testing. The purpose of this study was to identify factors which...

Full description

Bibliographic Details
Main Authors: Zhong Zheng, Xiaoming Zhao, Bing Xu, Ning Yao
Format: Article
Language:English
Published: Termedia Publishing House 2018-01-01
Series:Archives of Medical Science
Subjects:
Online Access:https://www.termedia.pl/What-should-we-focus-on-before-preimplantation-genetic-diagnosis-screening-,19,31510,1,1.html
_version_ 1828841848787959808
author Zhong Zheng
Xiaoming Zhao
Bing Xu
Ning Yao
author_facet Zhong Zheng
Xiaoming Zhao
Bing Xu
Ning Yao
author_sort Zhong Zheng
collection DOAJ
description Introduction : Preimplantation genetic diagnosis/screening (PGD/PGS) can effectively detect chromosomal abnormalities in an embryo but only if an embryo is available. However, not all couples can obtain an embryo that is available for testing. The purpose of this study was to identify factors which might affect the formation of PGD/PGS embryos to predict the possibility of obtaining embryos that could be detected. Material and methods : In a retrospective study, we included all couples who underwent PGD/PGS at our center from January 2015 to December 2016. We compared these patients according to the non-blastocyst group and the blastocyst group. Results : There were 302 couples who had blastocysts in their first PGD/PGS cycle. Fifty-seven couples had no blastocysts in their PGD/PGS cycles: 43 couples had no blastocysts in one cycle; 10 in two cycles; 4 in three cycles. The non-blastocyst group was older than the blastocyst group (32.37 vs. 30.69, p = 0.048). Anti-mullerian hormone (ng/ml) in the non-blastocyst group was significantly lower than in the blastocyst group (4.80 ±3.67 vs. 3.07 ±2.30, p = 0.00). Women whose chromosome were aneuploid (47, XXX or 45, X) had a similar AMH level compared with others, but the number of retrieved oocytes was much lower; the normal karyotype was 14.25 and aneuploidy was 5.40 (p = 0.01) in women < 30 years old. There was the same condition in women aged 30–38 years (14.60 vs. 3.44, p < 0.001). Male’s different chromosome karyotype had no influence on double pronuclear number or the rate of blastocyst formation. Presence of endometriosis, polycystic ovary syndrome and tubal factor showed no difference between the blastocyst and non-blastocyst group. Nor did oligospermia and asthenospermia. Conclusions : Elderly women, those with lower AMH and women with 47, XXX or 45, X have fewer ova, leading to the possibility of no blastocyst. These couples should be fully informed and weigh the advantages and disadvantages before undergoing PGD/PGS.
first_indexed 2024-12-12T20:12:31Z
format Article
id doaj.art-0f6a1ccd20194ea081bd761ab1b4689c
institution Directory Open Access Journal
issn 1734-1922
1896-9151
language English
last_indexed 2024-12-12T20:12:31Z
publishDate 2018-01-01
publisher Termedia Publishing House
record_format Article
series Archives of Medical Science
spelling doaj.art-0f6a1ccd20194ea081bd761ab1b4689c2022-12-22T00:13:29ZengTermedia Publishing HouseArchives of Medical Science1734-19221896-91512018-01-011451119112410.5114/aoms.2018.7279031510What should we focus on before preimplantation genetic diagnosis/screening?Zhong ZhengXiaoming ZhaoBing XuNing YaoIntroduction : Preimplantation genetic diagnosis/screening (PGD/PGS) can effectively detect chromosomal abnormalities in an embryo but only if an embryo is available. However, not all couples can obtain an embryo that is available for testing. The purpose of this study was to identify factors which might affect the formation of PGD/PGS embryos to predict the possibility of obtaining embryos that could be detected. Material and methods : In a retrospective study, we included all couples who underwent PGD/PGS at our center from January 2015 to December 2016. We compared these patients according to the non-blastocyst group and the blastocyst group. Results : There were 302 couples who had blastocysts in their first PGD/PGS cycle. Fifty-seven couples had no blastocysts in their PGD/PGS cycles: 43 couples had no blastocysts in one cycle; 10 in two cycles; 4 in three cycles. The non-blastocyst group was older than the blastocyst group (32.37 vs. 30.69, p = 0.048). Anti-mullerian hormone (ng/ml) in the non-blastocyst group was significantly lower than in the blastocyst group (4.80 ±3.67 vs. 3.07 ±2.30, p = 0.00). Women whose chromosome were aneuploid (47, XXX or 45, X) had a similar AMH level compared with others, but the number of retrieved oocytes was much lower; the normal karyotype was 14.25 and aneuploidy was 5.40 (p = 0.01) in women < 30 years old. There was the same condition in women aged 30–38 years (14.60 vs. 3.44, p < 0.001). Male’s different chromosome karyotype had no influence on double pronuclear number or the rate of blastocyst formation. Presence of endometriosis, polycystic ovary syndrome and tubal factor showed no difference between the blastocyst and non-blastocyst group. Nor did oligospermia and asthenospermia. Conclusions : Elderly women, those with lower AMH and women with 47, XXX or 45, X have fewer ova, leading to the possibility of no blastocyst. These couples should be fully informed and weigh the advantages and disadvantages before undergoing PGD/PGS.https://www.termedia.pl/What-should-we-focus-on-before-preimplantation-genetic-diagnosis-screening-,19,31510,1,1.htmlaneuploidy maternal age anti-mullerian preimplantation genetic screening preimplantation genetic diagnosis
spellingShingle Zhong Zheng
Xiaoming Zhao
Bing Xu
Ning Yao
What should we focus on before preimplantation genetic diagnosis/screening?
Archives of Medical Science
aneuploidy
maternal age
anti-mullerian
preimplantation genetic screening
preimplantation genetic diagnosis
title What should we focus on before preimplantation genetic diagnosis/screening?
title_full What should we focus on before preimplantation genetic diagnosis/screening?
title_fullStr What should we focus on before preimplantation genetic diagnosis/screening?
title_full_unstemmed What should we focus on before preimplantation genetic diagnosis/screening?
title_short What should we focus on before preimplantation genetic diagnosis/screening?
title_sort what should we focus on before preimplantation genetic diagnosis screening
topic aneuploidy
maternal age
anti-mullerian
preimplantation genetic screening
preimplantation genetic diagnosis
url https://www.termedia.pl/What-should-we-focus-on-before-preimplantation-genetic-diagnosis-screening-,19,31510,1,1.html
work_keys_str_mv AT zhongzheng whatshouldwefocusonbeforepreimplantationgeneticdiagnosisscreening
AT xiaomingzhao whatshouldwefocusonbeforepreimplantationgeneticdiagnosisscreening
AT bingxu whatshouldwefocusonbeforepreimplantationgeneticdiagnosisscreening
AT ningyao whatshouldwefocusonbeforepreimplantationgeneticdiagnosisscreening